SAMIYAH HOODBHOY: Open Payments
NPI 1245698117 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,823 in 41 payments from 11 companies in 2025. Trend: 2023 $409 · 2024 $424 · 2025 $4,823
Speaker / faculty: $4,000Food & beverage: $765Travel & lodging: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $4,213 |
| E.R. Squibb & Sons, L.L.C. | 4 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Alkermes, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Sage Therapeutics, LLC | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: VRAYLAR, COBENFY, CAPLYTA, FANAPT, INGREZZA, ARISTADA, ZURZUVAE, ABILIFY ASIMTUFII.
Industry payments across NV — which companies pay providers there.
